Causal influence of gut microbiota on small cell lung cancer: a Mendelian randomization study
- PMID: 38685730
- PMCID: PMC11058399
- DOI: 10.1111/crj.13764
Causal influence of gut microbiota on small cell lung cancer: a Mendelian randomization study
Abstract
Background: Previous studies have hinted at a significant link between lung cancer and the gut microbiome, yet their causal relationship remains to be elucidated.
Methods: GWAS data for small cell lung cancer (SCLC) was extracted from the FinnGen consortium, comprising 179 cases and 218 613 controls. Genetic variation data for 211 gut microbiota were obtained as instrumental variables from MiBioGen. Mendelian randomization (MR) was employed to determine the causal relationship between the two, with inverse variance weighting (IVW) being the primary method for causal analysis. The MR results were validated through several sensitivity analyses.
Results: The study identified a protective effect against SCLC for the genus Eubacterium ruminantium group (OR = 0.413, 95% CI: 0.223-0.767, p = 0.00513), genus Barnesiella (OR = 0.208, 95% CI: 0.0640-0.678, p = 0.00919), family Lachnospiraceae (OR = 0.319, 95% CI: 0.107-0.948, p = 0.03979), and genus Butyricimonas (OR = 0.376, 95% CI: 0.144-0.984, p = 0.04634). Conversely, genus Intestinibacter (OR = 3.214, 95% CI: 1.303-7.926, p = 0.01125), genus Eubacterium oxidoreducens group (OR = 3.391, 95% CI: 1.215-9.467, p = 0.01973), genus Bilophila (OR = 3.547, 95% CI: 1.106-11.371, p = 0.03315), and order Bacillales (OR = 1.860, 95% CI: 1.034-3.347, p = 0.03842) were found to potentially promote the onset of SCLC.
Conclusion: We identified potential causal relationships between certain gut microbiota and SCLC, offering new insights into microbiome-mediated mechanisms of SCLC pathogenesis, resistance, mutations, and more.
Keywords: Mendelian randomization; causality; gut microbiota; lung cancer; small cell lung cancer.
© 2024 The Authors. The Clinical Respiratory Journal published by John Wiley & Sons Ltd.
Conflict of interest statement
The authors declare no potential conflict of interest.
Figures
Similar articles
-
The Role of 418 Gut Microbiota in Small Cell Lung Cancer Progression: A Mendelian Randomisation Study.J Coll Physicians Surg Pak. 2025 Jan;35(1):60-65. doi: 10.29271/jcpsp.2025.01.60. J Coll Physicians Surg Pak. 2025. PMID: 39825539
-
Causal relationship between gut microbiota and lung squamous cell carcinoma: a bidirectional two-sample Mendelian randomization study.Postgrad Med J. 2025 May 18;101(1196):526-534. doi: 10.1093/postmj/qgae184. Postgrad Med J. 2025. PMID: 39690971
-
A Large Genetic Causal Analysis of the Gut Microbiota and Urological Cancers: A Bidirectional Mendelian Randomization Study.Nutrients. 2023 Sep 21;15(18):4086. doi: 10.3390/nu15184086. Nutrients. 2023. PMID: 37764869 Free PMC article.
-
Genetic liability of gut microbiota for idiopathic pulmonary fibrosis and lung function: a two-sample Mendelian randomization study.Front Cell Infect Microbiol. 2024 May 22;14:1348685. doi: 10.3389/fcimb.2024.1348685. eCollection 2024. Front Cell Infect Microbiol. 2024. PMID: 38841114 Free PMC article.
-
Exploring the potential causal relationship between gut microbiota and heart failure: A two-sample mendelian randomization study combined with the geo database.Curr Probl Cardiol. 2024 Feb;49(2):102235. doi: 10.1016/j.cpcardiol.2023.102235. Epub 2023 Nov 30. Curr Probl Cardiol. 2024. PMID: 38040216 Review.
Cited by
-
Macronutrient balance determines the human gut microbiome eubiosis: insights from in vitro gastrointestinal digestion and fermentation of eight pulse species.Front Microbiol. 2025 Jan 30;15:1512217. doi: 10.3389/fmicb.2024.1512217. eCollection 2024. Front Microbiol. 2025. PMID: 39949350 Free PMC article.
References
MeSH terms
LinkOut - more resources
Full Text Sources
Medical